ArticleEuropean archives of psychiatry and clinical neuroscience2025
Alexithymia as a mechanistic bridge: validating the mediating role of emotion processing deficits between childhood trauma and negative symptoms in schizophrenia.
Article in European archives of psychiatry and clinical neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
This pioneering study published in European Archives of Psychiatry and Clinical Neuroscience elucidates the mediating role of alexithymia-specifically difficulty identifying feelings (DIF) and externally oriented thinking (EOT)-in the pathway linking childhood trauma (CT) to negative symptoms (NS) in chronic schizophrenia (β < sub > DIF</sub > = 0.04, 95% CI [0.002, 0.085]; β < sub > EOT</sub > = 0.03, 95% CI [0.002, 0.060]). Using Hayes' PROCESS macro with bootstrapping in 94 patients, the authors establish alexithymia as a mechanistically actionable target for trauma-informed interventions. Methodological refinements are proposed to address antipsychotic class effects on emotion processing, neurobiological mediators (e.g., amygdala volume), and positive symptom confounding. This work redefines therapeutic paradigms for trauma-associated schizophrenia, underscoring the journal's leadership in transformative clinical neuroscience.
Indexed as
Identifiers
40773122What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.